Facebook Instagram Linkedin Youtube
Home Tags Spark Therapeutics

Tag: Spark Therapeutics

Comments from Orphazyme on the investment in CombiGene

Comments from Orphazyme on the investment in CombiGene

CombiGene focuses on the pain project

CombiGene focuses on the pain project

CombiGenes vd om det avslutade Spark-avtalet

CombiGene’s CEO on the terminated collaboration with Spark

CombiGene's CEO on the participation at BIO2023 in Boston

CombiGene’s CEO on the participation at BIO2023 in Boston

CombiGenes vd Jan Nilsson i BioStocks tv-studio i Sotckholm

Status update from CombiGene’s CEO

CombiGene-epilepsi

Article about CombiGene’s epilepsy project published in Gene Therapy

CombiGene

CombiGene’s pain project receives new scientific support

Jan Nilsson, vd CombiGene

CombiGene´s CEO provides an operational update

genterapi vid allvarlig hudsjukdom

Progress with a new gene therapy in severe skin disease

Combigene FDA approval Hemgenix

CombiGene’s CEO on the FDA approval of Hemgenix

12Page 1 of 2
© BioStock 2024